OCT 10, 2016 6:39 AM PDT

Protecting B Cell Chromosomes to Treat Non-Hodgkin's Lymphoma

WRITTEN BY: Kara Marker
One small change in the chromosomes of B lymphocytes, and the immune cells cannot proliferate and create antibodies to fight infection and cancer. A recent study shows that the protective abilities of a particular enzyme might be the key to a powerful population of protective B lymphocytes.
An enzyme called uracil-DNA glycosylase (UNG) protects the ends of B cell chromosomes so that the cells can continue to divide and give rise to antibodies to target foreign antigens. Researchers from Rockefeller University believe that promoting this protective mechanism could help treat certain types of non-Hodgkin’s lymphoma in addition to other infections. 

Another enzyme enters the picture once B cells begin proliferating due to a foreign antigen identified in the blood stream. Activation-induced deaminase, or AID, is a DNA-modifying enzyme that triggers mutations in the immunoglobulin genes of B cells that are responsible for the development of an increasingly diverse population of infection-fighting antibodies. This diverse population is particularly capable of strong binding of foreign antigens and the stimulation of various immune responses.

Unfortunately, the AID enzyme also has a “dark side;” the same mutations in makes in the B cell immunoglobulin genes can also lead to tumor growth in cancers like non-Hodgkin’s lymphoma. Even more, non-Hodgkin’s lymphoma tumor cells often overexpress AID on their own, exacerbating the growth of tumor cells.

The study from Rockefeller University investigated the potential of UNG to repair the mutations made in the B cell genome by AID enzymes to prevent the growth of non-Hodgkin’s lymphoma tumors: were AID enzymes targeting the telomeres of B cells? Using mouse models, scientists saw that without UNG, B cell telomere mutations from AID caused the ends of B cell chromosomes to rapidly shorten, drastically reducing the antibody-producing cells’ ability to proliferate.

"UNG can contribute to lymphomagenesis by protecting telomeres from AID-induced damage," said study leader Ramiro Verdun. "We show that cancerous human B cells expressing AID require UNG for proliferation, suggesting that targeting UNG may be a means to delay the growth of AID-positive cancers."

Verdun’s study was recently published in The Journal of Experimental Medicine.
 


Source: The Rockefeller University Press
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 27, 2019
Drug Discovery & Development
SEP 27, 2019
AI Exponentially Accelerates Drug Development
Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial in...
OCT 13, 2019
Microbiology
OCT 13, 2019
Molecule in Human Breast Milk Can Fight Microbial Pathogens
Now a team of scientists has found a molecule in human breast milk that may reduce the risk of illness and disease....
NOV 17, 2019
Cell & Molecular Biology
NOV 17, 2019
Scientists Reveal a Link Between Brain Fog and Inflammation
When people get sick, they often also feel tired, which can be as troublesome as their disease....
NOV 19, 2019
Microbiology
NOV 19, 2019
Ketogenic Diet Appears to Help Protect Against the Flu
The ketogenic diet forces the body to use stored fat as fuel instead of carbohydrates; the fat gets broken down into ketone bodies....
FEB 13, 2020
Immunology
FEB 13, 2020
Protein that suppresses immune system linked to lupus
  A study published in Human Immunology has described, for the first time, a link between an immunosuppressive protein on the surface of T cells and t...
FEB 19, 2020
Immunology
FEB 19, 2020
Testing the Immune Response to Ovarian Cancer Treatment
There is a new diagnostic test for the deadliest form of gynecological cancer – ovarian cancer. Better tests mean better diagnostics, and better diag...
Loading Comments...